AKT1 and keloid: This suppression of Akt signaling enhances apoptosis and markedly reduces fibroblast proliferation and migration, highlighting 17-AAG as a promising therapeutic agent for correcting the pathological hyperactivity of keloid fibroblasts (Yun et al., 2015).